These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 15034889)
1. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity. Li Q; da Silva MF; Pombeiro AJ Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889 [TBL] [Abstract][Full Text] [Related]
2. Polynuclear diorganotin(IV) complexes with arylhydroxamates: Syntheses, structures and in vitro cytotoxic activities. Shang X; Cui J; Wu J; Pombeiro AJ; Li Q J Inorg Biochem; 2008 Apr; 102(4):901-9. PubMed ID: 18234346 [TBL] [Abstract][Full Text] [Related]
3. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands. Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560 [TBL] [Abstract][Full Text] [Related]
4. Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells. Shang X; Ding N; Xiang G Eur J Med Chem; 2012 Feb; 48():305-12. PubMed ID: 22226547 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride. Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, antimicrobial and antitumor screening of some diorganotin(IV) complexes of 2-[(9H-Purin-6-ylimino)]-phenol. Rehman W; Badshah A; Khan S; Tuyet le TA Eur J Med Chem; 2009 Oct; 44(10):3981-5. PubMed ID: 19464768 [TBL] [Abstract][Full Text] [Related]
7. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH). Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688 [TBL] [Abstract][Full Text] [Related]
8. Redox-active cytotoxic diorganotin(IV) cycloalkylhydroxamate complexes with different ring sizes: reduction behaviour and theoretical interpretation. Shang X; Alegria EC; Guedes da Silva MF; Kuznetsov ML; Li Q; Pombeiro AJ J Inorg Biochem; 2012 Dec; 117():147-56. PubMed ID: 23085595 [TBL] [Abstract][Full Text] [Related]
9. One-step preparation, structural assignment, and X-ray study of 2,2-di-n-butyl- and 2,2-diphenyl-6-aza-1,3-dioxa-2-stannabenzocyclononen-4-ones derived from amino acids. Beltrán HI; Zamudio-Rivera LS; Mancilla T; Santillan R; Farfán N Chemistry; 2003 May; 9(10):2291-306. PubMed ID: 12772304 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes. Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659 [TBL] [Abstract][Full Text] [Related]
11. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds. Koch B; Baul TS; Chatterjee A J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, crystal structures, cytotoxicity and qualitative structure-activity relationship (QSAR) of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes, (n)Bu2Sn(L)2. Basu Baul TS; Mizar A; Chandra AK; Song X; Eng G; Jirásko R; Holcapek M; de Vos D; Linden A J Inorg Biochem; 2008 Sep; 102(9):1719-30. PubMed ID: 18571240 [TBL] [Abstract][Full Text] [Related]
13. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines. Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives. Trávnícek Z; Szucová L; Popa I J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304 [TBL] [Abstract][Full Text] [Related]
15. Macrocyclic diorganotin complexes of gamma-amino acid dithiocarbamates as hosts for ion-pair recognition. Cruz-Huerta J; Carillo-Morales M; Santacruz-Juárez E; Hernández-Ahuactzi IF; Escalante-García J; Godoy-Alcantar C; Guerrero-Alvarez JA; Höpfl H; Morales-Rojas H; Sánchez M Inorg Chem; 2008 Nov; 47(21):9874-85. PubMed ID: 18841933 [TBL] [Abstract][Full Text] [Related]
19. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction. Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377 [TBL] [Abstract][Full Text] [Related]
20. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA. Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]